| Inoculum effect of β-lactam antibiotics JR Lenhard, ZP Bulman Journal of Antimicrobial Chemotherapy 74 (10), 2825-2843, 2019 | 130 | 2019 |
| Therapeutic options for metallo-β-lactamase-producing enterobacterales X Tan, HS Kim, K Baugh, Y Huang, N Kadiyala, M Wences, N Singh, ... Infection and drug resistance, 125-142, 2021 | 87 | 2021 |
| High-dose ampicillin-sulbactam combinations combat polymyxin-resistant Acinetobacter baumannii in a hollow-fiber infection model JR Lenhard, NM Smith, ZP Bulman, X Tao, V Thamlikitkul, BS Shin, ... Antimicrobial Agents and Chemotherapy 61 (3), 10.1128/aac. 01268-16, 2017 | 83 | 2017 |
| Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use PJ Bergen, ZP Bulman, S Saju, JB Bulitta, C Landersdorfer, A Forrest, J Li, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (1 …, 2015 | 77 | 2015 |
| Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat DA Butler, M Biagi, X Tan, S Qasmieh, ZP Bulman, E Wenzler Current infectious disease reports 21, 1-17, 2019 | 74 | 2019 |
| Polymyxin Combinations Combat Escherichia coli Harboring mcr-1 and blaNDM-5: Preparation for a Postantibiotic Era ZP Bulman, L Chen, TJ Walsh, MJ Satlin, Y Qian, JB Bulitta, CA Peloquin, ... MBio 8 (4), 10.1128/mbio. 00540-17, 2017 | 63* | 2017 |
| A novel property of propolis (bee glue): anti-pathogenic activity by inhibition of N-acyl-homoserine lactone mediated signaling in bacteria Z Bulman, P Le, AO Hudson, MA Savka Journal of Ethnopharmacology 138 (3), 788-797, 2011 | 56 | 2011 |
| Pharmacodynamics of colistin and fosfomycin: a ‘treasure trove’ combination combats KPC-producing Klebsiella pneumoniae M Zhao, ZP Bulman, JR Lenhard, MJ Satlin, BN Kreiswirth, TJ Walsh, ... Journal of Antimicrobial Chemotherapy 72 (7), 1985-1990, 2017 | 54 | 2017 |
| Optimizing polymyxin combinations against resistant Gram-negative bacteria PJ Bergen, ZP Bulman, CB Landersdorfer, N Smith, JR Lenhard, ... Infectious Diseases and Therapy 4, 391-415, 2015 | 54 | 2015 |
| Genomic features associated with the degree of phenotypic resistance to carbapenems in carbapenem-resistant Klebsiella pneumoniae ZP Bulman, F Krapp, NB Pincus, E Wenzler, KR Murphy, C Qi, EA Ozer, ... Msystems 6 (5), 10.1128/msystems. 00194-21, 2021 | 38 | 2021 |
| Rational combinations of polymyxins with other antibiotics PJ Bergen, NM Smith, TB Bedard, ZP Bulman, R Cha, BT Tsuji Polymyxin antibiotics: from laboratory bench to bedside, 251-288, 2019 | 36 | 2019 |
| Research priorities towards precision antibiotic therapy to improve patient care ZP Bulman, SG Wicha, EI Nielsen, JR Lenhard, RL Nation, ... The Lancet Microbe 3 (10), e795-e802, 2022 | 35 | 2022 |
| Shifting gears: the future of polymyxin antibiotics JR Lenhard, ZP Bulman, BT Tsuji, KS Kaye Antibiotics 8 (2), 42, 2019 | 34 | 2019 |
| Activity of aztreonam in combination with avibactam, clavulanate, relebactam, and vaborbactam against multidrug-resistant Stenotrophomonas maltophilia M Biagi, D Lamm, K Meyer, A Vialichka, M Jurkovic, S Patel, RE Mendes, ... Antimicrobial Agents and Chemotherapy 64 (12), 10.1128/aac. 00297-20, 2020 | 33 | 2020 |
| A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA) I Shafiq, ZP Bulman, SL Spitznogle, JE Osorio, IS Reilly, AJ Lesse, ... Infectious Diseases 49 (5), 410-416, 2017 | 33 | 2017 |
| Klebsiella pneumoniae clinical isolates with features of both multidrug-resistance and hypervirulence have unexpectedly low virulence TJ Kochan, SH Nozick, A Valdes, SD Mitra, BH Cheung, M Lebrun-Corbin, ... Nature communications 14 (1), 7962, 2023 | 31 | 2023 |
| Optimization of polymyxin B in combination with doripenem to combat mutator Pseudomonas aeruginosa NS Ly, ZP Bulman, JB Bulitta, C Baron, GG Rao, PN Holden, J Li, ... Antimicrobial agents and chemotherapy 60 (5), 2870-2880, 2016 | 28 | 2016 |
| Evolution of Staphylococcus aureus under vancomycin selective pressure: the role of the small-colony variant phenotype JR Lenhard, C von Eiff, IS Hong, PN Holden, MD Bear, A Suen, ... Antimicrobial Agents and Chemotherapy 59 (2), 1347-1351, 2015 | 27 | 2015 |
| Sequential evolution of vancomycin-intermediate resistance alters virulence in Staphylococcus aureus: pharmacokinetic/pharmacodynamic targets for vancomycin exposure JR Lenhard, T Brown, MJ Rybak, CJ Meaney, NB Norgard, ZP Bulman, ... Antimicrobial Agents and Chemotherapy 60 (3), 1584-1591, 2016 | 22 | 2016 |
| Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020 N Singh, L Poggensee, Y Huang, CT Evans, KJ Suda, ZP Bulman JAC-Antimicrobial Resistance 4 (3), dlac049, 2022 | 21 | 2022 |
Jurgen BulittaUniversity of Floridabulitta.com의 이메일 확인됨
